Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Qurient Co., Ltd.
Essen Biotech
Revolution Medicines, Inc.
Perspective Therapeutics
Second Life Therapeutics
Tanabe Pharma America, Inc.
CRISPR Therapeutics
Laekna Limited
Sensei Biotherapeutics, Inc.
Cancer Research UK
NuCana plc
Medicenna Therapeutics, Inc.
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
NGM Biopharmaceuticals, Inc
OncoC4, Inc.
University Hospital, Antwerp
Kymab Limited
Cybrexa Therapeutics
Aminex Therapeutics, Inc.
NextCure, Inc.
NGM Biopharmaceuticals, Inc
Cancer Research UK
Second Affiliated Hospital of Guangzhou Medical University
Cancer Research and Biostatistics Clinical Trials Consortium
Genmab
Kineta Inc.
Incyte Corporation
Seagen Inc.
Gilead Sciences
Incyte Corporation
NKGen Biotech, Inc.
Seagen Inc.
Shenzhen BinDeBio Ltd.
Memorial Sloan Kettering Cancer Center
Celldex Therapeutics
Memorial Sloan Kettering Cancer Center
Aronex Pharmaceuticals